Chong‐Xian Pan
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
- Cancer Cells and Metastasis 3
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 3
- Internal Medicine top 10%
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments 10
-
- DNA Repair Mechanisms 4
-
- Radiopharmaceutical Chemistry and Applications 3
- Co-authors
- Liang ChengJohn N. EbleTimothy D. JonesGregory T. MacLennanAntonio López-BeltránXiming J. YangMichael O. KochPrimo N. Lara
- Journals
- Molecular Cancer Therapeutics (3 papers)Expert Review of Anticancer Therapy (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Chong‐Xian Pan
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 237
- Oncology 421
- Pulmonary and Respiratory Medicine 478
- Internal Medicine 41
- Surgery 344
Countries citing papers authored by Chong‐Xian Pan
This map shows the geographic impact of Chong‐Xian Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐Xian Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐Xian Pan more than expected).
Fields of papers citing papers by Chong‐Xian Pan
This network shows the impact of papers produced by Chong‐Xian Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐Xian Pan. The network helps show where Chong‐Xian Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chong‐Xian Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 63 | |
| 3 | 2021 | 7 | |
| 4 | 2021 | 20 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 32 | |
| 10 | 2017 | 27 | |
| 11 | 2016 | 22 | |
| 12 | 2016 | 8 | |
| 13 | 2014 | 9 | |
| 14 | 2011 | 21 | |
| 15 | 2011 | 23 | |
| 16 | 2011 | 6 | |
| 17 | 2005 | 92 | |
| 18 | 2005 | 97 | |
| 19 | 2005 | 30 | |
| 20 | 2005 | 144 |
About Chong‐Xian Pan
Chong‐Xian Pan is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Cancer Genomics and Diagnostics (8 papers), Prostate Cancer Treatment and Research (5 papers), DNA Repair Mechanisms (4 papers), Peptidase Inhibition and Analysis (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Renal cell carcinoma treatment (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (237 citations), Oncology (421 citations) and Pulmonary and Respiratory Medicine (478 citations). Chong‐Xian Pan has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Liang Cheng, John N. Eble, Timothy D. Jones, Gregory T. MacLennan, Antonio López-Beltrán, Ximing J. Yang, Michael O. Koch, Primo N. Lara, Hongyong Zhang and Lee Ann Baldridge. Their work appears in journals such as Molecular Cancer Therapeutics, Expert Review of Anticancer Therapy, Journal of Clinical Oncology, Chemical Research in Toxicology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.